Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 10.6k | $23.23 | $246.2k | | 01/06/2023 |
01/06/2023 | ANAPTYSBIO, INC | ANAB | Grant | Restricted Stock Unit | 3.9k | $0.00 | $0 | | 01/06/2023 |
02/10/2022 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 9.2k | $30.44 | $280k | | 02/10/2022 |
02/10/2021 | ANAPTYSBIO, INC | ANAB | Grant | Stock Option (right to buy) | 11k | $29.70 | $326.7k | | 02/10/2021 |
07/02/2020 | PORTOLA PHARMACEUTICALS INC | PTLA | Disposition | Common Stock | 13.2k | $18.00 | $237.5k | | 07/02/2020 |
07/02/2020 | PORTOLA PHARMACEUTICALS INC | PTLA | Disposition | Restricted Stock Units | 7.3k | $18.00 | $131.1k | | 07/02/2020 |
07/02/2020 | PORTOLA PHARMACEUTICALS INC | PTLA | Disposition | Stock Option (Right to Buy) | 11.4k | $11.94 | $135.8k | | 07/02/2020 |
07/02/2020 | PORTOLA PHARMACEUTICALS INC | PTLA | Disposition | Stock Option (Right to Buy) | 45k | $0.00 | $0 | | 07/02/2020 |
06/12/2020 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Common Stock | 7.3k | $0.00 | $0 | | 06/12/2020 |
06/12/2020 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Stock Option (Right to Buy) | 11.4k | $17.94 | $204.1k | | 06/12/2020 |
02/12/2020 | ANAPTYSBIO, INC | ANAB | Grant | Director Stock Option (Right to Buy) | 11k | $16.56 | $182.2k | | 02/12/2020 |
06/13/2019 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Common Stock | 4.2k | $0.00 | $0 | | 06/13/2019 |
06/13/2019 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Stock Option (Right to Buy) | 7k | $26.09 | $182.4k | | 06/13/2019 |
05/30/2019 | Sienna Biopharmaceuticals, Inc. | SNNA | Grant | Stock Options (Right to buy) | 25k | $1.22 | $30.5k | | 05/30/2019 |
02/08/2019 | ANAPTYSBIO, INC | ANAB | Grant | Director Stock Option (Right to Buy) | 6k | $68.89 | $413.3k | | 02/08/2019 |
06/08/2018 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Common Stock | 3k | $0.00 | $0 | | 06/08/2018 |
06/08/2018 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Stock Option (Right to Buy) | 6k | $42.81 | $256.9k | | 06/08/2018 |
06/01/2018 | Sienna Biopharmaceuticals, Inc. | SNNA | Grant | Stock Options (Right to buy) | 10k | $15.08 | $150.8k | | 06/01/2018 |
03/05/2018 | ANAPTYSBIO, INC | ANAB | Grant | Director Stock Option (right to buy) | 6k | $118.97 | $713.8k | | 03/05/2018 |
03/05/2018 | ANAPTYSBIO, INC | ANAB | Grant | Director Stock Option (right to buy) | 5.5k | $118.97 | $655.2k | | 03/05/2018 |
09/18/2017 | Sienna Biopharmaceuticals, Inc. | SNNA | Purchase | Common Stock | 1.2k | $22.96 | $28.7k | | 09/18/2017 |
06/16/2017 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Common Stock | 3k | $0.00 | $0 | | 06/16/2017 |
06/16/2017 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Stock Option (Right to Buy) | 6k | $35.06 | $210.4k | | 06/16/2017 |
05/05/2017 | Pfenex Inc. | PFNX | Grant | Stock Option (right to buy) | 18k | $4.92 | $88.6k | | 05/05/2017 |
06/17/2016 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Common Stock | 3k | $0.00 | $0 | | 06/17/2016 |
06/17/2016 | PORTOLA PHARMACEUTICALS INC | PTLA | Grant | Stock Option (Right to Buy) | 6k | $24.19 | $145.1k | | 06/17/2016 |
05/06/2016 | Pfenex Inc. | PFNX | Grant | Stock Option (right to buy) | 18k | $8.10 | $145.8k | | 05/06/2016 |
06/04/2013 | KYTHERA BIOPHARMACEUTICALS INC | KYTH | Grant | Stock Option (right to buy) | 6.6k | $21.65 | $143.3k | | 06/04/2013 |
10/16/2012 | KYTHERA BIOPHARMACEUTICALS INC | KYTH | Conversion | Common Stock | 1.5k | $0.00 | $0 | | 10/16/2012 |
10/16/2012 | KYTHERA BIOPHARMACEUTICALS INC | KYTH | Conversion | Common Stock | 1.9k | $0.00 | $0 | See footnote | 10/16/2012 |
10/16/2012 | KYTHERA BIOPHARMACEUTICALS INC | KYTH | Conversion | Series A Preferred Stock | 1.5k | $0.00 | $0 | | 10/16/2012 |
10/16/2012 | KYTHERA BIOPHARMACEUTICALS INC | KYTH | Conversion | Series C Preferred Stock | 1.9k | $0.00 | $0 | See footnote | 10/16/2012 |
10/10/2012 | KYTHERA BIOPHARMACEUTICALS INC | KYTH | Grant | Stock Option (right to buy) | 5.7k | $16.00 | $90.8k | | 10/10/2012 |
06/16/2010 | GENZYME CORP | GENZ | Grant | Restricted Stock Units | 2.4k | $0.00 | $0 | | 06/16/2010 |
06/16/2010 | GENZYME CORP | GENZ | Grant | Stock Option (right to buy) | 7.1k | $51.52 | $367.1k | | 06/16/2010 |
|